glp 1 from weight watchers Introducing the new Everyone's got an opinion on

Administration of GLP-2-2G-XTEN resulted in a significant increase in small intestine weight and length as well as reduced inflammation scores and proinflammatory cytokines (Alters et al

Model-based meta-analysis: an important tool for making quantitative decisions during drug development

In 2025, the Endocrine Society reported signals from preclinical and early clinical research suggesting that GLP-1 receptor agonists may reduce nicotine- and alcohol-seeking behavior and the risk of relapse

18 Another study using data from the Swedish Registers found a significantly lower risk of DR among patients who used a GLP-1 RA compared with those who did not